We need to talk about…CRISPR – BioNews
|
We need to talk about…CRISPR
BioNews The genome editing technique CRISPR has been used to edit human embryos in vitro (see BioNews 911) – and no, not in China, that’s so 2015: now we are talking about the USA. That was my pre-vacation experience this summer. I clicked on my news feed … |
U.S. News & World Report |
Ignoring the Future Won’t Forestall It
U.S. News & World Report Some scientists have called for extreme caution moving forward; others are responding by preparing kids for a new world that might soon include “Clustered Regularly Interspaced Short Palindromic Repeats,” or CRISPR for short, biotechnology that allows … |
Doctor NDTV |
Two studies find vitamin C can prevent and treat leukemia
The San Diego Union-Tribune A study released Monday found that human and mouse hematopoietic stem cells absorb unusually large amounts of vitamin C. When the cells were depleted of vitamin C, they were more likely to turn into leukemia cells. The results indicate the importance … Vitamin C Can Suppress Leukemia – Up To a Point | IFLScienceIFLScience Vitamin C injections could play a role in treating blood cancersNHS Choices Vitamin C May Help Kill Blood Cancer Cells – Doctor NDTVDoctor NDTV Lymphoma News Today all 8 news articles » |
Doctor NDTV |
Two studies find vitamin C can prevent and treat leukemia
The San Diego Union-Tribune A study released Monday found that human and mouse hematopoietic stem cells absorb unusually large amounts of vitamin C. When the cells were depleted of vitamin C, they were more likely to turn into leukemia cells. The results indicate the importance … Vitamin C Can Suppress Leukemia – Up To a Point | IFLScienceIFLScience Vitamin C injections could play a role in treating blood cancersNHS Choices Vitamin C May Help Kill Blood Cancer Cells – Doctor NDTVDoctor NDTV Lymphoma News Today all 8 news articles » |
Innovators Magazine |
$13M for synthetic biology research
Innovators Magazine Researchers in Australia are making advances in synthetic biology (SynBio) thanks to the support of a multi-million dollar fund. The CSIRO Synthetic Biology Future Science Platform (SynBio FSP) is a $13 million shot in the arm for the country’s … |
|
Spark’s Gene Therapy SPK-8011 to Treat Hemophilia A and B Advance in Clinical Trials
Hemophilia News Today Three patients who received SPK-8011 — a gene therapy developed by Spark Therapeutics — for hemophilia A show increased production of clotting factor VIII without any safety issues reported, says the company. The patients are the first to receive the … |
BusinessCloud |
Stem cell disrupter WideCells raises £750k
BusinessCloud A company which aims to facilitate the use of stem cells in treating disease has raised £750,000 in a private placing and been named among the world’s most disruptive companies. WideCells Group PLC is based at the University of Manchester Innovation … |